PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tumor-Induced Osteomalacia

Ultragenyx and Kyowa Kirin's Crysvita (burosumab) Receive the US FDA's Approval for the Treatment of Tumor-Induced Osteomalacia

Ultragenyx and Kyowa Kirin's Crysvita (burosumab) Receive the US FDA's Approval for the Treatment of Tumor-Induced Osteomalacia

June 19, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us